Evolent Health, Inc. (EVH)
3.53
+0.07
(+2.02%)
USD |
NYSE |
Oct 05, 12:45
Evolent Health Net Income (Quarterly) : -28.36M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -28.36M |
| March 31, 2026 | -26.63M |
| December 31, 2025 | -429.13M |
| September 30, 2025 | -20.86M |
| June 30, 2025 | -19.90M |
| March 31, 2025 | -64.62M |
| December 31, 2024 | -22.80M |
| September 30, 2024 | -23.14M |
| June 30, 2024 | 1.596M |
| March 31, 2024 | -17.28M |
| December 31, 2023 | -33.41M |
| September 30, 2023 | -25.32M |
| June 30, 2023 | -34.32M |
| March 31, 2023 | -19.98M |
| December 31, 2022 | -11.35M |
| September 30, 2022 | 2.123M |
| June 30, 2022 | -4.125M |
| March 31, 2022 | -5.35M |
| December 31, 2021 | 3.053M |
| September 30, 2021 | -13.04M |
| June 30, 2021 | -9.107M |
| March 31, 2021 | -11.19M |
| December 31, 2020 | -10.64M |
| September 30, 2020 | -37.04M |
| June 30, 2020 | -202.01M |
| Date | Value |
|---|---|
| March 31, 2020 | -78.49M |
| December 31, 2019 | -199.29M |
| September 30, 2019 | -25.74M |
| June 30, 2019 | -31.90M |
| March 31, 2019 | -48.65M |
| December 31, 2018 | -17.54M |
| September 30, 2018 | -12.56M |
| June 30, 2018 | -10.03M |
| March 31, 2018 | -14.06M |
| December 31, 2017 | -13.79M |
| September 30, 2017 | -13.13M |
| June 30, 2017 | -19.70M |
| March 31, 2017 | -23.15M |
| December 31, 2016 | -25.19M |
| September 30, 2016 | -15.78M |
| June 30, 2016 | -12.00M |
| March 31, 2016 | -173.81M |
| December 31, 2015 | -8.267M |
| September 30, 2015 | -17.09M |
| June 30, 2015 | 356.49M |
| March 31, 2015 | -11.32M |
| December 31, 2014 | -11.99M |
| September 30, 2014 | -4.446M |
| June 30, 2014 | -5.939M |
| March 31, 2014 | -5.442M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| DarioHealth Corp. | -7.924M |
| CompuMed, Inc. | 0.0247M |
| Teladoc Health, Inc. | -38.91M |
| Renalytix Plc | -- |
| Lifestance Health Group, Inc. | 23.61M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 652.52M |
| Total Expenses (Quarterly) | 680.88M |
| EPS Diluted (Quarterly) | -0.252 |
| Enterprise Value | 1.222B |
| Gross Profit Margin (Quarterly) | 9.08% |
| Profit Margin (Quarterly) | -4.35% |
| Earnings Yield | -129.5% |
| Normalized Earnings Yield | -54.03 |